122 related articles for article (PubMed ID: 38230074)
1. Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9815950. PubMed ID: 38230074
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Oncology JO
J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
[TBL] [Abstract][Full Text] [Related]
7. Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
Zhang K; Xie K; Huo X; Liu L; Liu J; Zhang C; Wang J
Biomed Res Int; 2022; 2022():9168441. PubMed ID: 36246969
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9818549. PubMed ID: 38077877
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2023; 2023():9841321. PubMed ID: 38075334
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
[TBL] [Abstract][Full Text] [Related]
12. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9813798. PubMed ID: 38152740
[TBL] [Abstract][Full Text] [Related]
16. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
[TBL] [Abstract][Full Text] [Related]
17. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
International BR
Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9786174. PubMed ID: 38077938
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
International BR
Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]